Literature DB >> 19691169

Medicare program; inpatient rehabilitation facility prospective payment system for federal fiscal year 2010. Final rule.

.   

Abstract

This final rule updates the payment rates for inpatient rehabilitation facilities (IRFs) for Federal fiscal year (FY) 2010 (for discharges occurring on or after October 1, 2009 and on or before September 30, 2010) as required under section 1886(j)(3)(C) of the Social Security Act (the Act). Section 1886(j)(5) of the Act requires the Secretary to publish in the Federal Register on or before the August 1 that precedes the start of each fiscal year, the classification and weighting factors for the IRF prospective payment system's (PPS) case-mix groups and a description of the methodology and data used in computing the prospective payment rates for that fiscal year. We are revising existing policies regarding the IRF PPS within the authority granted under section 1886(j) of the Act.

Entities:  

Mesh:

Year:  2009        PMID: 19691169

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  3 in total

1.  Thrombolysis with intravenous tissue plasminogen activator predicts a favorable discharge disposition in patients with acute ischemic stroke.

Authors:  Nneka L Ifejika-Jones; Nusrat Harun; Nareesa A Mohammed-Rajput; Elizabeth A Noser; James C Grotta
Journal:  Stroke       Date:  2011-02-03       Impact factor: 7.914

2.  Age- and sex-specific predictors of inpatient rehabilitation facility discharge destination for adult patients with traumatic brain injury.

Authors:  Tolu O Oyesanya; Gabrielle Harris; Michael P Cary; Lindsey Byom; Qing Yang; Janet Prvu Bettger
Journal:  Brain Inj       Date:  2021-09-20       Impact factor: 2.311

3.  Predictors of cognitive gains during inpatient rehabilitation for older adults with traumatic brain injury.

Authors:  Lindsey Byom; Amy T Zhao; Qing Yang; Tolu Oyesanya; Gabrielle Harris; Michael P Cary; Janet Prvu Bettger
Journal:  PM R       Date:  2022-03-01       Impact factor: 2.218

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.